dk Life Science Communications gives “new impetus to Okedi®” for schizophrenia
dk Life Science Communications is delighted to welcome another new customer: The pharmaceutical company ROVI, manufacturer of the innovative drug Okedi® for the treatment of schizophrenia, is relying on the expertise of the Frankfurt-based healthcare specialists.
“Communicating about mental illness requires sensitivity, specialist knowledge and experience – and that’s exactly what we bring to the table,” says dk Managing Director Dr. Andreas Kloevekorn. “We are delighted about the trust placed in us and the task set by ROVI.”
With its novel galenics, the long-acting antipsychotic Okedi® is particularly suitable for modern schizophrenia therapy – a “perfect match”. The dk team is now using its expertise to communicate this knowledge in a catchy way and to activate the practitioners.
The budget includes traditional PR, the development of target group-specific communication measures and, in particular, the expansion of digital activities: The agency is designing an online knowledge platform to bundle all content and measures.
“dk caught our interest with its strategic approach to further anchor Okedi® with new communicative impulses in the treatment of patients with schizophrenia,” says Dr. Stefan Peters, Business Unit Director Psychiatry at Holzkirchen-based ROVI GmbH: “The mix of craftsmanship, consulting services and fresh ideas for storytelling and its implementation convinced us to work together.”
ROVI GmbH is the German branch of the internationally active Spanish pharmaceutical company Laboratorios Farmacéuticos ROVI, S.A., which specializes in innovative medicines.
About dk Life Science Communications
dk Life Science Communications has been one of the leading German communications agencies in the healthcare sector for over 30 years and is based in Frankfurt. The agency has been part of the WEFRA LIFE Group since 2023.
Media contact
Dr. Andreas Kloevekorn
dk Life Science Communications GmbH
Falkstrasse 5
60487 Frankfurt am Main
Phone: +49 69 61998-0
Fax: +49 69 61998-10
dkcommunications.com
